£385K
The funding round features investment from members of Henley Business Angels to advance rapid microbiology testing.
Astratus develops rapid testing technology to combat antimicrobial resistance.
Astratus is a University of Reading spin-out developing rapid microbiology testing technology to accelerate personalised antimicrobial prescribing.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from Astratus's latest Companies House filing — with year-on-year movement, free with a Winfred account.
The funding round features investment from members of Henley Business Angels to advance rapid microbiology testing.